Eli Lilly & Co. Stock Underperforms Thursday When Compared To CompetitorsMarketWatch Automated·37 minutes agoLLY-4.55%LLYZ0.00%
Johnson & Johnson Stock (JNJ) Moved Down by 3.49% on Jul 30: Key Drivers UnveiledTradingKey·4 hours agoJNJ-3.66%
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Dealsbenzinga_article·5 hours agoJNJ-3.66%
Eli Lilly and Co Stock (LLY) Moved Down by 4.09% on Jul 30: Key Drivers UnveiledTradingKey·5 hours agoLLY-4.55%ELIL-9.36%
09:25 ETPOZITÍVNE STANOVISKO VÝBORU PRE LIEKY NA HUMÁNNE POUŽITIE PODPORUJE ŠIRŠIE POUŽÍVANIE LIEKU REPATHA® OD SPOLOČNOSTI AMGEN PRED PRVÝM INFARKTOM ALEBO MOZGOVOU PRÍHODOUprnewswire·7 hours agoAMGN0.00%
J&J’s Rybrevant Faspro wins FDA priority review for advanced head and neck cancer treatmentPUBT·8 hours agoJNJ-3.66%
Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stockbenzinga_article·8 hours agoRGTI+12.41%MMYT-0.12%
3 Companies Including MercadoLibre That May Be Trading Below Their Estimated ValueSimplywall·9 hours agoWDAY-5.89%LLY-4.55%
Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular usePharmaceutical Technology·11 hours agoAMGN0.00%
One of the market's 'most durable growth' sectors has been passed over for AI, says JPMorganDow Jones·13 hours agoLLY-4.55%DHR-0.16%
Dow Jones Top Company Headlines at 1 AM ET: Meta Stumbles as Tech Investors Demand Better Answers on AI Spending | Even ...MorningStar·15 hours agoARM+7.40%BX-1.03%
Dow Jones Top Company Headlines at 7 PM ET: Microsoft Profits Jump 31% as Azure Cloud Sales Surpass $100 Billion | Meta ...MorningStar·21 hours agoCVNA-7.36%META-7.95%
